Bio-Techne Corp (TECH)
Interest coverage
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 133,848 | 202,548 | 234,287 | 236,584 | 246,400 | 261,162 | 268,020 | 294,182 | 297,722 | 274,920 | 282,488 | 274,075 | 277,432 | 231,048 | 215,027 | 202,581 | 189,368 | 238,835 | 215,879 | 196,551 |
Interest expense (ttm) | US$ in thousands | 8,509 | 8,840 | 10,838 | 13,019 | 15,736 | 16,929 | 14,291 | 12,318 | 11,215 | 10,018 | 11,144 | 11,690 | 11,309 | 12,095 | 12,262 | 12,945 | 13,952 | 15,278 | 17,104 | 18,391 |
Interest coverage | 15.73 | 22.91 | 21.62 | 18.17 | 15.66 | 15.43 | 18.75 | 23.88 | 26.55 | 27.44 | 25.35 | 23.45 | 24.53 | 19.10 | 17.54 | 15.65 | 13.57 | 15.63 | 12.62 | 10.69 |
June 30, 2025 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $133,848K ÷ $8,509K
= 15.73
The interest coverage ratios of Bio-Techne Corp over the specified periods demonstrate a generally favorable capacity to meet interest obligations from operating earnings. This metric, which measures the company's ability to cover interest expenses with its earnings before interest and taxes (EBIT), exhibits notable fluctuations from September 2020 through June 2025.
Initially, the ratio increased from 10.69 in September 2020 to a peak of 27.44 in March 2023, indicating a strengthening position in covering interest costs and suggesting improved operational profitability and/or reduced interest expenses. The highest interest coverage was observed on March 31, 2023.
Subsequently, the ratio experienced a decline, falling to 18.75 by December 2023, before continuing downward trend estimates to 15.43 by March 2024, and stabilizing around 15.66 on June 2024. A slight recovery is seen later, with ratios reaching 21.62 in December 2024 and 22.91 in March 2025, indicating a renewed upward trend in coverage capacity.
Overall, the interest coverage ratios illustrate that Bio-Techne Corp maintained a robust buffer over the analyzed period, particularly during the years from 2020 through early 2023. The decline observed thereafter suggests some easing in either operational earnings or increasing interest obligations but remains within a range that generally indicates a comfortable margin for debt servicing. Variability across periods reflects changes in profitability, interest expenses, and possibly strategic financial management practices.
Peer comparison
Jun 30, 2025